Investment Summary |
|
|---|---|
| Date | 2015-08-03 |
| Target | GENERA d.d. |
| Sector | Life Science |
| Investor(s) | Dechra Pharmaceuticals |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Life Science |
| Revenue | 682M GBP (2022) |
Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 16 |
| Sector: Life Science M&A | 8 of 14 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Croatia M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-20 |
PSPC
Melbourne, Florida, United States PSPC , Inc. is a veterinary joint supplement for dogs and horses that contains glucosamine, MSM, creatine, antioxidants and phycocyanin. Phycocyanin is an extract from blue-green algae that has a patent which supports its use as a COX-2 selective agent that alleviates pain and inflammation without the side effects that occur with non-steroidal anti-inflammatory drugs that are not COX-2 selective. The product is currently sold through a distributor into approximately 3,000 of the US' 26,000 companion animal veterinary clinics. |
Buy | $10M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-14 |
Laboratorios Brovel S.A. de C.V.
Mexico City, Mexico Laboratorios Brovel S.A. de C.V. is a veterinary pharmaceuticals company. |
Buy | £4M |
